MARKET

TMBR

TMBR

BIOPHARMX
AMEX

Real-time Quotes | Nasdaq Last Sale

2.560
-0.100
-3.76%
Opening 11:12 06/02 EDT
OPEN
2.650
PREV CLOSE
2.660
HIGH
2.650
LOW
2.500
VOLUME
235.28K
TURNOVER
--
52 WEEK HIGH
14.16
52 WEEK LOW
2.450
MARKET CAP
46.79M
P/E (TTM)
-0.0214
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TMBR stock price target is 2.250 with a high estimate of 2.250 and a low estimate of 2.250.

EPS

TMBR News

More
71 Biggest Movers From Friday
Gainers Inari Medical, Inc. (NASDAQ: NARI) shares surged 123.7% to close at $42.51 on Friday after pricing its IPO on Friday.
Benzinga · 05/26 08:30
Timber Pharmaceuticals Announces Investor Conference Call
Call to be held on Tuesday, May 26th at 11:00 am EDT Woodcliff Lake, New Jersey--(Newsfile Corp. - May 23, 2020) - Timber Pharmaceuticals, Inc. (NYSE American: TMBR) ("Timber" or the "Company"), a biopharmaceutical company focused on the development and commer
Newsfile · 05/23 19:27
70 Biggest Movers From Yesterday
Gainers Cheetah Mobile Inc. (NYSE: CMCM) shares surged 47.3% to close at $3.05 on Wednesday after the company reported a $1.44 per ADS special dividend and agreed to sell remaining equity ownership in Bytedance for $66 million.
Benzinga · 05/21 09:22
52 Stocks Moving In Wednesday's Mid-Day Session
Gainers AeroCentury Corp. (NYSE: ACY) shares jumped 80.3% to $3.9305.
Benzinga · 05/20 17:17
Timber Pharmaceuticals Announces Investor Conference Call
WOODCLIFF LAKE, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan d
GlobeNewswire · 05/19 20:41
82 Biggest Movers From Yesterday
Gainers cbdMD, Inc. (NASDAQ: YCBD) rose 81.4% to close at $1.76 following strong Q2 earnings.
Benzinga · 05/19 08:44
62 Stocks Moving In Monday's Mid-Day Session
Gainers ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares climbed 71.3% to $0.5480 after reporting Q2 results. ALJ Regional’s quarterly sales rose to $96.00 million from $87.996 million.
Benzinga · 05/18 16:43
26 Stocks Moving in Monday's Pre-Market Session
Gainers ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares rose 87.5% to $0.60 in pre-market trading after reporting Q2 results. ALJ Regional’s quarterly sales rose to $96.00 million from $87.996 million.
Benzinga · 05/18 11:15

Industry

Biotechnology & Medical Research
-1.85%
Pharmaceuticals & Medical Research
-0.90%

Hot Stocks

Symbol
Price
%Change

About TMBR

Timber Pharmaceuticals, Inc., formerly BioPharmX Corporation, is a biopharmaceutical company. The Company is focused on the development and commercialization of treatments for orphan dermatologic diseases. It is developing treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma. Its pipeline includes TMB-001, TMB-002 and TMB-003. TMB-001 is a topical isotretinoin, which is being developed for the treatment of moderate to severe subtypes of CI. TMB-002, a topical rapamycin, is being developed for the treatment of facial angiofibromas (FAs) in TSC. TMB-003 is a topical / subcutaneous ET-A receptor antagonist, which is being developed for localized scleroderma.
More

Webull offers kinds of Timber Pharmaceuticals Inc stock information, including AMEX:TMBR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TMBR stock news, and many more online research tools to help you make informed decisions.